Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0650
-0.0020 (-2.99%)
Sep 18, 2026, 1:54 PM AEST
Noxopharm Cash Flow Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Net Income | -4.46 | -4.88 | -3.58 | -15.06 | -18.67 |
Depreciation & Amortization | 0 | 0 | 0 | 0.15 | 0.26 |
Loss (Gain) From Sale of Assets | - | - | - | 0.06 | - |
Loss (Gain) From Sale of Investments | - | -0.47 | -1.05 | 4.45 | 8.86 |
Stock-Based Compensation | - | 0.06 | - | 0.01 | 0.8 |
Other Operating Activities | 1.74 | -0.09 | 0 | 0.02 | 0.08 |
Change in Accounts Receivable | - | -0.57 | 3.7 | -0.48 | 0.18 |
Change in Inventory | - | - | - | 1.15 | -0.83 |
Change in Accounts Payable | - | 0.08 | 0.2 | -1.08 | -4.33 |
Change in Other Net Operating Assets | - | 0.04 | 0.03 | -0.18 | -0.08 |
Operating Cash Flow | -2.71 | -5.82 | -0.68 | -10.95 | -13.73 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Investment in Securities | - | 2.48 | - | - | - |
Other Investing Activities | - | - | - | 0.12 | - |
Investing Cash Flow | - | 2.48 | - | 0.12 | - |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Short-Term Debt Issued | 1.8 | 4.4 | 2 | - | - |
Total Debt Issued | 1.8 | 4.4 | 2 | - | - |
Short-Term Debt Repaid | -0.35 | -1.8 | -2 | - | - |
Long-Term Debt Repaid | - | - | - | -0.18 | -0.23 |
Lease Payments | - | - | - | -0.18 | -0.23 |
Total Debt Repaid | -0.35 | -1.8 | -2 | -0.18 | -0.23 |
Net Debt Issued (Repaid) | 1.45 | 2.6 | - | -0.18 | -0.23 |
Issuance of Common Stock | - | - | - | - | 1.2 |
Financing Cash Flow | 1.45 | 2.6 | - | -0.18 | 0.98 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Foreign Exchange Rate Adjustments | 0 | -0.02 | -0 | -0 | -0.03 |
Net Cash Flow | -1.26 | -0.77 | -0.69 | -11 | -12.79 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -2.71 | -5.82 | -0.68 | -10.95 | -13.73 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -190.06% | -206.48% | -28.51% | -182.13% | -252.98% |
Free Cash Flow Per Share | -0.01 | -0.02 | -0.00 | -0.04 | -0.05 |
Levered Free Cash Flow | -1.77 | -4.05 | 1.09 | -7 | -10.19 |
Unlevered Free Cash Flow | -1.06 | -3.73 | 1.11 | -6.97 | -10.15 |
Free Cash Flow After Leases | -2.71 | -5.82 | -0.68 | -11.12 | -13.96 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash Interest Paid | 0.39 | 0.07 | 0.03 | 0.02 | 0.02 |
Cash Income Tax Paid | -2.81 | -2.34 | -6.05 | -5.01 | -5.86 |
Change in Working Capital | - | -0.45 | 3.94 | -0.59 | -5.07 |